Langerhans Cell Histiocytosis After Hodgkin Lymphoma: A Case Report
Author Information
Author(s): Dehkordi Nahid Reisi, Rajabi Parvin, Naimi Azar, Heidarpour Mitra
Primary Institution: Isfahan University of Medical Sciences
Hypothesis
The occurrence of Langerhans Cell Histiocytosis (LCH) in a patient with Hodgkin lymphoma suggests a probable relationship between the two conditions.
Conclusion
LCH can occur after Hodgkin lymphoma, and accurate histopathologic evaluation is crucial for correct diagnosis.
Supporting Evidence
- LCH occurrence after Hodgkin lymphoma is seen in less than 0.3% of cases.
- The patient was treated with chemotherapy and radiotherapy for Hodgkin lymphoma before developing LCH.
- Histopathologic examination confirmed the diagnosis of LCH following Hodgkin lymphoma.
Takeaway
This study talks about a boy who got a rare disease called LCH after having another disease called Hodgkin lymphoma, showing that sometimes one illness can lead to another.
Methodology
The case involved clinical diagnosis, treatment, and follow-up, along with histopathologic examination and immunohistochemistry.
Limitations
The occurrence of LCH after Hodgkin lymphoma is rare, and the study is based on a single case report.
Participant Demographics
A 10-year-old boy.
Want to read the original?
Access the complete publication on the publisher's website